Emergence of SARS-CoV-2 Omicron (B. 1.1. 529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic
Since the appearance in the late of December 2019, SARS-CoV-2 is rapidly evolving and
mutating continuously, giving rise to various variants with variable degrees of infectivity and …
mutating continuously, giving rise to various variants with variable degrees of infectivity and …
Clinical update on COVID-19 for the emergency clinician: Presentation and evaluation
Introduction Coronavirus disease of 2019 (COVID-19) has resulted in millions of cases
worldwide. As the pandemic has progressed, the understanding of this disease has evolved …
worldwide. As the pandemic has progressed, the understanding of this disease has evolved …
[HTML][HTML] Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies
Newly emerging variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
are continuously posing high global public health concerns and panic resulting in waves of …
are continuously posing high global public health concerns and panic resulting in waves of …
[HTML][HTML] Omicron variant (B. 1.1. 529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
M Dhawan, ARA Saied, S Mitra, FA Alhumaydhi… - Biomedicine & …, 2022 - Elsevier
Since the start of the COVID-19 pandemic, numerous variants of SARS-CoV-2 have been
reported worldwide. The advent of variants of concern (VOCs) raises severe concerns amid …
reported worldwide. The advent of variants of concern (VOCs) raises severe concerns amid …
[HTML][HTML] Ophthalmic manifestations of coronavirus (COVID-19)
K Hu, J Patel, C Swiston, BC Patel - StatPearls [Internet], 2022 - ncbi.nlm.nih.gov
Objectives: Summarize the epidemiology of ocular manifestations of COVID-19. Describe
the typical presentation of a patient with ocular manifestations of COVID-19. Outline …
the typical presentation of a patient with ocular manifestations of COVID-19. Outline …
OMICRON: Virology, immunopathogenesis, and laboratory diagnosis
Since its emersion, coronavirus disease 2019 (COVID‐19) has been a significant global
dilemma. Several mutations in the severe acute respiratory virus (SARS‐Co‐2) genome has …
dilemma. Several mutations in the severe acute respiratory virus (SARS‐Co‐2) genome has …
Omicron variant (B. 1.1. 529) of SARS-CoV-2: understanding mutations in the genome, S-glycoprotein, and antibody-binding regions
The Omicron variant has been detected in nearly 150 countries. We analyzed the mutational
landscape of Omicron throughout the genome, focusing the S-glycoprotein. We also …
landscape of Omicron throughout the genome, focusing the S-glycoprotein. We also …
Effectiveness of COVID-19 vaccines against Delta (B. 1.617. 2) variant: a systematic review and meta-analysis of clinical studies
The high transmissibility, mortality, and morbidity rate of the SARS-CoV-2 Delta (B. 1.617. 2)
variant have raised concerns regarding vaccine effectiveness (VE). To address this issue, all …
variant have raised concerns regarding vaccine effectiveness (VE). To address this issue, all …
[HTML][HTML] Current status of oral antiviral drug treatments for SARS-CoV-2 infection in non-hospitalized patients
DV Parums - … science monitor: international medical journal of …, 2022 - ncbi.nlm.nih.gov
On 4 th November 2021, the first oral antiviral drug for COVID-19, molnupiravir (Lagevrio®),
received full regulatory approval from the Medicines and Healthcare Products Regulatory …
received full regulatory approval from the Medicines and Healthcare Products Regulatory …
Advances in oligosaccharides production from algal sources and potential applications
In recent years, algal-derived glycans and oligosaccharides have become increasingly
important in health applications due to higher bioactivities than plant-derived …
important in health applications due to higher bioactivities than plant-derived …